Evidence map›Paper›PMID 35770406›Full record

ReviewReviews on recent clinical trials2022

Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update.

Rocco Spagnuolo, Antonio Basile, Alessandro Corea, Francesco Salvatore Iaquinta, Nataša Milić, Patrizia Doldo, Francesco Luzza, Ludovico Abenavoli

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reviews on recent clinical trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Rocco SpagnuoloDepartment of Clinical and Experimental Medicine, Magna Graecia, University of Catanzaro, Calabria, Catanzaro, Italy.ORCID 0000-0002-0871-4644
Antonio BasileDepartment of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.
Alessandro CoreaDepartment of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.
Francesco Salvatore IaquintaDepartment of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.ORCID 0000-0001-9740-1203
Nataša MilićDepartment of Pharmacy, University of Novi Sad, Novi Sad, Serbia.
Patrizia DoldoDepartment of Clinical and Experimental Medicine, Magna Graecia, University of Catanzaro, Calabria, Catanzaro, Italy.
Francesco LuzzaDepartment of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.
Ludovico AbenavoliDepartment of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.ORCID 0000-0002-5922-1524
Magna Graecia University · ITUniversity of Novi Sad · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnxiety and depression are the most common psychological disorders found in Inflammatory Bowel Disease (IBD) patients. Accurate measuring of these disorders should be proposed for prompt management. Patient-reported outcome measurements (PROMs) allow patients to self-report their psychological symptoms.

objectiveThe objective of this study is to highlight the presence of PROMs measuring anxiety and depression in IBD setting, evaluating the most used psychometric tools.

methodsWe reviewed the literature from 2010 up to September 2021. Articles on adult IBD patients assessing depression and anxiety by PROMs in English language were included.

resultsThirty-six studies, including 11 psychometric tools were found. Hospital Anxiety and Depression Scale (21 studies), Beck Depression Inventory II (5 studies), Spielberg State-Trait Anxiety Inventory (3 studies), Patient-Reported Outcomes Measurement Information System (3 studies), Symptom Checklist-90 (2 studies), Euro Quality of Life (2 studies) mostly used psychometric tools for anxiety and depression in IBD settings.

conclusionOur review analyzed psychometric tools used for PROMs evaluating anxiety and depression in IBD setting. No chronological differences have emerged, all have been used in the last ten years, highlighting lack of specificity. The strong association between IBD and mood disorders suggests that clinicians should consider the evaluation of depression and anxiety as integral parts of IBD clinical care. It is essential to identify tools enabling these items to be detected better. A global view of IBD patients, accounting not only for physical but also for psychical symptoms with an early and feasible assessment of unrecognized psychiatric disorders, can have a strong impact on their management strategy.

Indexed as

Anxiety DisordersInflammatory Bowel DiseasesMood DisordersPatient Reported Outcome MeasuresHumansPsychometricsQuality of Lifeanxietydepressionhospital anxiety and depression scale (HADS)Inflammatory bowel diseasepatient-reported outcome measurement information system (PROMIS).patient-reported outcome measurements (PROMs)quality of life

Identifiers

PMID35770406
OpenAlexW4283740838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.